161 related articles for article (PubMed ID: 38110105)
1. Women's Preferences for Hypofractionated Radiation Therapy for Treatment of Early-Stage Breast Cancer: A Discrete Choice Experiment.
Howard K; Norris S; Salisbury A; Pearce A; Hay L; Stapleton B; Lean C; Last A; Kwedza R; White K; Rushton S
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):172-184. PubMed ID: 38110105
[TBL] [Abstract][Full Text] [Related]
2. Women's Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment.
Sicsic J; Pelletier-Fleury N; Moumjid N
Value Health; 2018 Jan; 21(1):78-88. PubMed ID: 29304944
[TBL] [Abstract][Full Text] [Related]
3. Investigating the Heterogeneity in Women's Preferences for Breast Screening: Does the Communication of Risk Matter?
Vass CM; Rigby D; Payne K
Value Health; 2018 Feb; 21(2):219-228. PubMed ID: 29477404
[TBL] [Abstract][Full Text] [Related]
4. Review of Factors Influencing Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic Review.
Gu J; Groot G; Boden C; Busch A; Holtslander L; Lim H
Clin Breast Cancer; 2018 Aug; 18(4):e539-e554. PubMed ID: 29396079
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
[TBL] [Abstract][Full Text] [Related]
6. Trade-offs between overall survival and side effects in the treatment of metastatic breast cancer: eliciting preferences of patients with primary and metastatic breast cancer using a discrete choice experiment.
Bullen A; Ryan M; Ennis H; Gray E; Loría-Rebolledo LE; McIntyre M; Hall P
BMJ Open; 2024 Apr; 14(4):e076798. PubMed ID: 38684245
[TBL] [Abstract][Full Text] [Related]
7. What Breast Cancer Screening Program do Rural Women Prefer? A Discrete Choice Experiment in Jiangsu, China.
Sun Y; Wang Y; Zhang H; Hu Z; Ma Y; He Y
Patient; 2024 Jul; 17(4):363-378. PubMed ID: 38483691
[TBL] [Abstract][Full Text] [Related]
8. Women's preferences for attributes of first-trimester miscarriage management: a stated preference discrete-choice experiment.
Petrou S; McIntosh E
Value Health; 2009 Jun; 12(4):551-9. PubMed ID: 18798807
[TBL] [Abstract][Full Text] [Related]
9. Patient preference for a long-acting recombinant FSH product in ovarian hyperstimulation in IVF: a discrete choice experiment.
van den Wijngaard L; Rodijk IC; van der Veen F; Gooskens-van Erven MH; Koks CA; Verhoeve HR; Mol BW; van Wely M; Mochtar MH
Hum Reprod; 2015 Feb; 30(2):331-7. PubMed ID: 25432926
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing the surgery intentions and choices of women with early breast cancer: the predictive utility of an extended theory of planned behaviour.
Sivell S; Elwyn G; Edwards A; Manstead AS;
BMC Med Inform Decis Mak; 2013 Aug; 13():92. PubMed ID: 23962230
[TBL] [Abstract][Full Text] [Related]
11. My mind is made up: Cancer concern and women's preferences for contralateral prophylactic mastectomy.
De Abreu Lourenço R; Haas M; Hall J; Parish K; Stuart D; Viney R
Eur J Cancer Care (Engl); 2019 Jul; 28(4):e13058. PubMed ID: 31006930
[TBL] [Abstract][Full Text] [Related]
12. The perspective of women with an increased risk of OHSS regarding the safety and burden of IVF: a discrete choice experiment.
Braam SC; de Bruin JP; Mol BWJ; van Wely M
Hum Reprod Open; 2020; 2020(2):hoz034. PubMed ID: 32123754
[TBL] [Abstract][Full Text] [Related]
13. How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment.
Marshall DA; Deal K; Bombard Y; Leighl N; MacDonald KV; Trudeau M
BMJ Open; 2016 Jun; 6(6):e010981. PubMed ID: 27256091
[TBL] [Abstract][Full Text] [Related]
14. Patient preferences for locoregional therapy in early-stage breast cancer.
Minami CA; King TA; Mittendorf EA
Breast Cancer Res Treat; 2020 Sep; 183(2):291-309. PubMed ID: 32691377
[TBL] [Abstract][Full Text] [Related]
15. Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care.
Pillay J; Guitard S; Rahman S; Saba S; Rahman A; Bialy L; Gehring N; Tan M; Melton A; Hartling L
Syst Rev; 2024 May; 13(1):140. PubMed ID: 38807191
[TBL] [Abstract][Full Text] [Related]
16. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
[TBL] [Abstract][Full Text] [Related]
17. Women's preference to apply shared decision-making in breast cancer screening: a discrete choice experiment.
Hernández-Leal MJ; Pérez-Lacasta MJ; Cardona-Cardona A; Codern-Bové N; Vidal-Lancis C; Rue M; Forné C; Carles-Lavila M;
BMJ Open; 2022 Nov; 12(11):e064488. PubMed ID: 36351714
[TBL] [Abstract][Full Text] [Related]
18. Differences in Preferences for Drug Therapy Between Patients with Metastatic Versus Early-Stage Breast Cancer: A Systematic Literature Review.
Brandstetter LS; Jírů-Hillmann S; Störk S; Heuschmann PU; Wöckel A; Reese JP
Patient; 2024 Jul; 17(4):349-362. PubMed ID: 38451419
[TBL] [Abstract][Full Text] [Related]
19. Patient preferences and predicted relative uptake for targeted therapies in metastatic colorectal cancer: a discrete choice experiment.
Wong XY; Lim AQJ; Shen Q; Chia JWK; Chew MH; Tan WS; Wee HL
Curr Med Res Opin; 2020 Oct; 36(10):1677-1686. PubMed ID: 32609014
[TBL] [Abstract][Full Text] [Related]
20. Women's preferences for less active ectopic pregnancy treatment: A discrete choice experiment.
Capmas P; Panjo H; Artignan J; Babelhadj A; Benoist I; Decouzon J; Jarrige C; Leglise M; Renoncet V; Pelletier-Fleury N
Eur J Obstet Gynecol Reprod Biol; 2024 Jan; 292():175-181. PubMed ID: 38035866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
